Sanofi says Gaucher disease pill meets goal in late-stage trial
Home page > News

Sanofi says Gaucher disease pill meets goal in late-stage trial

www.reuters.com   | 02.10.2012.

PARIS (Reuters) - Sanofi's experimental pill to treat Gaucher disease, a rare inherited condition, has met its main goal in a late-stage trial, the French drugmaker said on Tuesday.
br />

Patients treated with the drug, eliglustat tartrate, showed a statistically significant improvement in the size of their spleen after nine months compared with those who took a placebo, Sanofi said in a statement.

(Reporting by Elena Berton; Editing by Edwina Gibbs)


Comments (0) Add Your comment Add news < Previous news Next news >






  Add your news >>>